ZM 323881 hydrochloride

CAS No. 193000-39-4

ZM 323881 hydrochloride ( —— )

Catalog No. M13023 CAS No. 193000-39-4

ZZZM 323881 hydrochloride is a potent and selective VEGFR2 inhibitor with IC50 of <2 nM, almost no activity on VEGFR1, PDGFRβ, FGFR1, EGFR and ErbB2.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 59 In Stock
10MG 93 In Stock
25MG 224 In Stock
50MG 383 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ZM 323881 hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    ZZZM 323881 hydrochloride is a potent and selective VEGFR2 inhibitor with IC50 of <2 nM, almost no activity on VEGFR1, PDGFRβ, FGFR1, EGFR and ErbB2.
  • Description
    ZZZM 323881 hydrochloride is a potent and selective VEGFR2 inhibitor with IC50 of <2 nM, almost no activity on VEGFR1, PDGFRβ, FGFR1, EGFR and ErbB2.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR; FGFR1; PDGFRβ; VEGFR1; VEGFR2
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    193000-39-4
  • Formula Weight
    411.86
  • Molecular Formula
    C22H19ClFN3O2
  • Purity
    >98%(HPLC)
  • Solubility
    DMSO: 10 mg/mL (24.28 mM)
  • SMILES
    Cl.CC1=CC(F)=C(NC2=NC=NC3=C2C=CC(OCC2=CC=CC=C2)=C3)C=C1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Whittles CE, et al. Microcirculation, 2002, 9(6), 513-522.
molnova catalog
related products
  • CCF642

    CCF642 is a novel PDI-inhibiting compound with antimyeloma activity.

  • Cetuximab (anti-EGFR...

    Cetuximab (anti-EGFR) is an inhibitor of epidermal growth factor receptor (EGFR).

  • Matuzumab

    Matuzumab is a humanized monoclonal antibody used in cancer treatment. It has a high affinity for EGFR frequently associated with the growth of blood vessels in malignancy facilitating tumor growth and survival.